Coloplast A/S

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:43 2024-05-14 EDT			5-day change	1st Jan Change
835 ^DKK	-1.07%		-0.88%	+8.16%

05-07	European shares hit one-month high as earnings take centre stage	RE
05-07	U.S. Futures Flat, European Stocks Rise	DJ

Coloplast A/S Provides Earnings Guidance for Fiscal Year 2023-2024

November 09, 2023 at 01:33 am

Coloplast A/S provided earnings guidance for Fiscal year 2023-2024. For the year company expects, organic revenue growth of around 8% and an EBIT margin of 27%-28%.

Latest news about Coloplast A/S

European shares hit one-month high as earnings take centre stage	05-07	RE
U.S. Futures Flat, European Stocks Rise	05-07	DJ
European shares hit one-month high on upbeat earnings, rate-cut optimism	05-07	RE
Transcript : Coloplast A/S, H1 2024 Earnings Call, May 07, 2024	05-07
Coloplast Posts Higher Fiscal H1 Net Profit, Revenue	05-07	MT
Coloplast Strengthens Ostomy Care Portfolio with Three Significant Product Launches	05-07	CI
Coloplast A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-07	CI
Coloplast A/S Revises Earnings Guidance for the Fiscal Year 2023/24	05-07	CI
Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024	05-07	CI
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	02-26	CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat	02-14
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders	02-09	DJ
Global markets live: Tesco, Boeing, Roche, Exxon Mobil, PepsiCo...	02-09
Transcript : Coloplast A/S, Q1 2024 Earnings Call, Feb 09, 2024	02-09
European shares flat as higher yields counter earnings bump	02-09	RE
European shares inch up on earnings bump, higher yields weigh	02-09	RE
Coloplast Posts Growth in Fiscal Q1 Net Profit, Revenue	02-09	MT
Coloplast Launches Peristeen Light for People with Bowel Disorders	02-09	CI
Coloplast A/S Reports Earnings Results for the First Quarter Ended December 31, 2023	02-09	CI
Coloplast A/S Reaffirms Earnings Guidance for the Fiscal Year 2023/24	02-09	CI
Coloplast Rolls Out New Silicone Foam for Wound Care in US	01-31	MT
Coloplast A/SLaunches Biatain® Silicone Fit for Pressure Injury Prevention and Wound Management in the US	01-31	CI
Nordic Stocks Decreased Wednesday; Kone B Posted Biggest Loss	01-17	DJ
COLOPLAST : EPS cut (2023: -12.9%, 2024: -14.7%)	01-04
Coloplast A/S Approves the Distribution of Year-End Dividend	12-07	CI

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-20 - Q3 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

COLOPLAST : Q1 24: Many more positives beyond the margin beat

February 14, 2024 at 11:08 am

More Strategies

Ratings for Coloplast A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

835 DKK

Average target price

912.3 DKK

Spread / Average Target

+9.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
COLOPLAST A/S	+8.16%	27.22B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-29.43%	3.14B
WINNER MEDICAL CO., LTD.	-17.85%	2.47B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+12.41%	2.35B
HARTALEGA HOLDINGS	+9.63%	2.14B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-3.79%	2.03B
NAKANISHI INC.	+5.36%	1.34B
KOSSAN RUBBER INDUSTRIES	+28.65%	1.29B
KANGJI MEDICAL HOLDINGS LIMITED	+9.30%	1.19B
GVS S.P.A.	+5.83%	1.12B

Medical Supplies

Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Coloplast A/S Provides Earnings Guidance for Fiscal Year 2023-2024

Latest news about Coloplast A/S

Chart Coloplast A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Coloplast A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Supplies